May 2008
Volume 49, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2008
The Quasi-Integrated Porous Polyethylene Implant in Pediatric Patients Enucleated for Retinoblastoma
Author Affiliations & Notes
  • D. P. Marx
    Department of Ophthalmology, Baylor College of Medicine, Houston, Texas
  • M. R. Vagefi
    The Center for Facial Appearances, Salt Lake City, Utah
  • W. H. Bearden
    Virginia Eye Institute, Richmond, Virginia
  • R. L. Anderson
    The Center for Facial Appearances, Salt Lake City, Utah
  • M. T. Yen
    Department of Ophthalmology, Baylor College of Medicine, Houston, Texas
  • Footnotes
    Commercial Relationships  D.P. Marx, None; M.R. Vagefi, None; W.H. Bearden, None; R.L. Anderson, Porex Surgical, Inc., P; M.T. Yen, None.
  • Footnotes
    Support  None.
Investigative Ophthalmology & Visual Science May 2008, Vol.49, 2299. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      D. P. Marx, M. R. Vagefi, W. H. Bearden, R. L. Anderson, M. T. Yen; The Quasi-Integrated Porous Polyethylene Implant in Pediatric Patients Enucleated for Retinoblastoma. Invest. Ophthalmol. Vis. Sci. 2008;49(13):2299. doi: https://doi.org/.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To describe the clinical outcomes of patients receiving a quasi-integrated porous polyethylene orbital implant following enucleation for retinoblastoma.

Methods: : A retrospective review of all retinoblastoma patients who received the quasi-integrated porous polyethylene implant following enucleation during the 56-month period between October 2000 and May 2005 was conducted.

Results: : Ten patients were identified who received the quasi-integrated porous polyethylene implant as a buried, primary orbital implant. Approximately 6 weeks following implantation, a custom-fitted prosthesis was made by an impression technique to provide a "lock-and-key" fit with the orbital implant in the majority of patients. Follow-up ranged from 2 months to 78.5 months following surgery, with an average of 36 months. One case of implant exposure was noted, with no other significant complications. Good motility of the prosthesis was noted in all cases.

Conclusions: : The quasi-integrated porous polyethylene orbital implant is safe to implant and provides good prosthetic motility without the need for pegs or screws. It was associated with an exposure rate similar to other commonly used implants following enucleation in retinoblastoma cases.

Keywords: retinoblastoma • orbit 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×